CME Sponsor:
Imedex

Location:
Pod
Philidelphia, Pennsylvania

Series Chair:
Ramaswamy Govindan, MD
Washington University School of Medicine
St Louis, Missouri

Number of Credits:
2.0 AMA PRA Category 1 CreditTM

Registration:
This is a complimentary educational dinner meeting for physicians. There is no cost to attend this activity or to obtain CME credits.

The educational content of this series is for PHYSICIANS ONLY. At this time we are not accepting registrations from those who are not practicing physicians.

You may register online by Thursday, September 29, 2011. Registration confirmations will be issued before the meeting. Seating is limited so please register in advance. If you have not registered in advance please call (678) 242-0920 to confirm that space is available.

For easy registration, feel free to call (512) 708-4678.

Link

Detailed Description:
This educational activity is specifically designed for medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists, and other physicians in active clinical practice interested and/or involved in the management of patients with lung cancer. After successful completion of this course, participants should be able to: select a therapeutic regimen based upon histology, deduce the appropriate role of biologic, molecular and genetic markers that guide the therapeutic decision- making process, and evaluate the clinical utility of two novel agents for the management and treatment of patients with NSCLC.

Learning Objectives:
After successful completion of this course, participants should be able to:
    - Select a therapeutic regimen based upon histology
    - Deduce the appropriate role of biologic, molecular and genetic markers that guide the therapeutic decision- making process
    - Evaluate the clinical utility of two novel agents for the management and treatment of patients with NSCLC